Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A comparative characterization of dipentameric (IgM)(2) and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use.

Tarköy M, Wyss M, Rudolf MP.

J Pharm Biomed Anal. 2010 Apr 6;51(5):1084-90. doi: 10.1016/j.jpba.2009.11.003. Epub 2009 Nov 13.

PMID:
20005064
2.

Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.

Horn MP, Zuercher AW, Imboden MA, Rudolf MP, Lazar H, Wu H, Hoiby N, Fas SC, Lang AB.

Antimicrob Agents Chemother. 2010 Jun;54(6):2338-44. doi: 10.1128/AAC.01142-09. Epub 2010 Mar 22.

3.

Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.

Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB.

Invest Ophthalmol Vis Sci. 1997 Jun;38(7):1418-25.

PMID:
9191605
4.

Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.

Collins MS, Ladehoff DK, Mehton NS, Noonan JS.

FEMS Microbiol Immunol. 1990 Dec;2(5-6):263-8.

PMID:
2127368
5.

Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.

Secher T, Fauconnier L, Szade A, Rutschi O, Fas SC, Ryffel B, Rudolf MP.

J Antimicrob Chemother. 2011 May;66(5):1100-9. doi: 10.1093/jac/dkr038. Epub 2011 Feb 24.

PMID:
21393169
6.

Pseudomonas aeruginosa antigens as potential vaccines.

Stanislavsky ES, Lam JS.

FEMS Microbiol Rev. 1997 Nov;21(3):243-77. Review.

7.

Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa.

Lam JS, MacDonald LA, Lam MY, Duchesne LG, Southam GG.

Infect Immun. 1987 May;55(5):1051-7. Erratum in: Infect Immun 1987 Dec;55(12):3240.

8.
10.

Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.

Lang AB, Fürer E, Senyk G, Larrick JW, Cryz SJ Jr.

Hum Antibodies Hybridomas. 1990;1(2):96-103.

PMID:
2129420
11.

Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.

O'Oka H, Chonan E, Mizutani K, Fukuda T, Kuroiwa Y, Ono Y, Shigeta S.

Microbiol Immunol. 1992;36(12):1305-16.

12.

Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.

Zweerink HJ, Gammon MC, Hutchison CF, Jackson JJ, Lombardo D, Miner KM, Puckett JM, Sewell TJ, Sigal NH.

Infect Immun. 1988 Aug;56(8):1873-9.

13.

Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently.

Schreiber JR, Cooper LJ, Diehn S, Dahlhauser PA, Tosi MF, Glass DD, Patawaran M, Greenspan NS.

J Infect Dis. 1993 Jan;167(1):221-6.

PMID:
8418172
15.

Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains.

Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L.

J Immunol. 2004 Nov 1;173(9):5671-8. Erratum in: J Immunol. 2007 Jun 1;178(11):7485.

17.
18.

The role of a functionally distinct IgM anti-type III pneumococcal polysaccharide (SIII) in low-dose paralysis to SIII in mice.

Kearney R, Andrews J, Johnstone S.

Aust J Exp Biol Med Sci. 1986 Feb;64 ( Pt 1):19-35.

PMID:
2938567
19.

Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection.

Uezumi I, Terashima M, Kohzuki T, Kato M, Irie K, Ochi H, Noguchi H.

Antimicrob Agents Chemother. 1992 Jun;36(6):1290-5.

20.

Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers.

Lazar H, Horn MP, Zuercher AW, Imboden MA, Durrer P, Seiberling M, Pokorny R, Hammer C, Lang AB.

Antimicrob Agents Chemother. 2009 Aug;53(8):3442-6. doi: 10.1128/AAC.01699-08. Epub 2009 May 18.

Supplemental Content

Support Center